Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Daimler Truck meldet starkes EBIT für Q3 2025 trotz Marktherausforderungen (Investing.com DE) +++ DAIMLER TRUCK Aktie -3,03%

TANDEM DIABETES Aktie

 >TANDEM DIABETES Aktienkurs 
13.995 EUR    +21.3%    (Tradegate)
Ask: 13.995 EUR / 179 Stück
Bid: 13.515 EUR / 556 Stück
Tagesumsatz: 375 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>TANDEM DIABETES Performance
1 Woche: -6,8%
1 Monat: -6,7%
3 Monate: -1,3%
6 Monate: -39,1%
1 Jahr: -62,2%
laufendes Jahr: -66,3%
>TANDEM DIABETES Aktie
Name:  TANDEM DIABETES NEW -,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US8753722037 / A2H5BX
Symbol/ Ticker:  TD5A (Frankfurt) / TNDM (NASDAQ)
Kürzel:  FRA:TD5A, ETR:TD5A, TD5A:GR, NASDAQ:TNDM
Index:  -
Webseite:  https://www.tandemdiabete..
Profil:  Tandem Diabetes Care Inc. is a medical device comp..
>Volltext..
Marktkapitalisierung:  892.4 Mio. EUR
Unternehmenswert:  1005.61 Mio. EUR
Umsatz:  869.82 Mio. EUR
EBITDA:  -75.6 Mio. EUR
Nettogewinn:  -178.4 Mio. EUR
Gewinn je Aktie:  -2.68 EUR
Schulden:  389.88 Mio. EUR
Liquide Mittel:  55.67 Mio. EUR
Operativer Cashflow:  8.44 Mio. EUR
Bargeldquote:  1.25
Umsatzwachstum:  14.43%
Gewinnwachstum:  -36.87%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  TANDEM DIABETES
Letzte Datenerhebung:  07.11.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 67.57 Mio. St.
Frei handelbar: 98.99%
Rückkaufquote: 0.57%
Mitarbeiter: 2650
Umsatz/Mitarb.: 0.31 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 31.52%
Bewertung:
KGV: -
KGV lG: -
KUV: 1.02
KBV: 7.96
PEG-Ratio: -0.1
EV/EBITDA: -
Rentabilität:
Bruttomarge: 52.55%
Gewinnmarge: -20.51%
Operative Marge: -10.4%
Managementeffizenz:
Gesamtkaprendite: -22.66%
Eigenkaprendite: -111.91%
>Peer Group

Es sind 597 Aktien bekannt.
 
07.11.25 - 03:21
 Tandem Diabetes Care outlines path to $1B sales milestone and gross margin gains in 2025 while expanding pharmacy channel (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.11.25 - 01:45
 Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
 
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers....
07.11.25 - 01:00
 Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
 
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of 0.00% and +4.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
07.11.25 - 00:09
 Tandem Diabetes Care soars after double Q3 beats (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 22:24
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
31.10.25 - 23:30
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
30.10.25 - 16:30
 Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
 
Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
26.10.25 - 14:03
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Oct. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
23.10.25 - 17:18
 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM (PR Newswire)
 
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
22.10.25 - 01:24
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
16.10.25 - 10:24
 TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm (PR Newswire)
 
LOS ANGELES, Oct. 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or "the Company") (NASDAQ: TNDM) for violations of the securities laws.......
16.10.25 - 02:54
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Oct. 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
15.10.25 - 20:57
 Breaking Down Tandem Diabetes Care: 13 Analysts Share Their Views (Benzinga)
 
Latest Ratings for TNDM DateFirmActionFromTo Feb 2022Wells FargoMaintainsOverweight Feb 2022CitigroupMaintainsBuy Feb 2022SVB LeerinkMaintainsMarket Perform View More Analyst Ratings for TNDM View the Latest Analyst Ratings read more...
13.10.25 - 20:01
 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM (PR Newswire)
 
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
11.10.25 - 00:03
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued......
08.10.25 - 22:39
 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM (PR Newswire)
 
NEW YORK, Oct. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
03.10.25 - 18:48
 INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM (PR Newswire)
 
NEW YORK, Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
02.10.25 - 22:06
 Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025 (Business Wire)
 
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial markets close on Thursday, November 6, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2025 financial and operating results. A live webcast of the call will be available on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section. To access the call by phone, please use this link (https://register-conf.media-server.com/register/BIc606fdd6dfdd4cec879c519f6530a5c6) and you will be provided with dial-in details, including a personal pin. An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the “Ev...
28.09.25 - 19:54
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have......
24.09.25 - 02:57
 Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM (PR Newswire)
 
NEW YORK, Sept. 23, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Bildung scheint mir das einzige Ziel, das des Bestrebens, Wahrheit der einzige Reichtum, der des Besitzes würdig ist. - Heinrich von Kleist
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!